Chymase Angiotensin-(1-12) Axis In Hypertensive Disease
Status:
Recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
Determine the presence of the human sequence of Angiotensin-(1-12) in plasma of ten untreated
hypertensive subjects and after 4 week with Lisinopril 40 mg every day. Determine the blood
pressure reduction with Lisinopril 40mg.
Phase:
Phase 4
Details
Lead Sponsor:
Trinity Hypertension & Metabolic Research Institute